“Treating Relapsed Refractory Acute Myeloid Leukemia With Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor With Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Treating Relapsed Refractory Acute Myeloid Leukemia With Chidamide, Fludarabine, Cytarabine and G-CSF”. 2022. Mediterranean Journal of Hematology and Infectious Diseases 14 (1): e2022025. https://doi.org/10.4084/MJHID.2022.025.